Strategies to sensitize cancer cells to immunotherapy

Area of Science:

• Oncology
• Immunology
• Cancer Therapy

Background:

• Immunotherapy has emerged as a significant cancer treatment modality.
• However, its effectiveness is limited by drug resistance and hyperprogression in some patients.
• Overcoming these challenges is crucial for improving patient outcomes.

Purpose of the Study:

• To explore tumor sensitization as a strategy to enhance immunotherapy efficacy.
• To investigate methods for circumventing immunotherapy resistance and preventing hyperprogression.
• To categorize tumor sensitization approaches based on their targets.

Main Methods:

• Review and categorization of existing tumor sensitization strategies.
• Analysis of tumor-intrinsic and tumor cell-extrinsic sensitization mechanisms.
• Evaluation of how these strategies counteract immune resistance in refractory tumors.

Main Results:

• Tumor sensitization strategies can be broadly classified into tumor-intrinsic and tumor cell-extrinsic approaches.
• Tumor-intrinsic strategies target cancer cells to reduce their immune-suppressive properties.
• Tumor cell-extrinsic strategies modify the tumor microenvironment to enhance immunotherapy.

Conclusions:

• Tumor sensitization holds potential for improving the effectiveness of immunotherapies, including immune checkpoint inhibitors.
• These strategies may help overcome resistance and potentially prevent immunotherapy-induced hyperprogression.
• Targeting either tumor-intrinsic or extrinsic factors can pave the way for more successful cancer immunotherapy.